Full-Time

Quality Engineer

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Position requires onsite presence.

Category
QA & Testing
Quality Assurance
Requirements
  • 6+ years of relevant experience in medical device industry; relevant experience in Risk Management; experience in connected devices is highly appreciated.
  • Ability to collaborate effectively with peers, stakeholders, and partners across the organization to positively impact business results.
  • Knowledge in problem solving methodologies.
  • Knowledge of ISO 13485, ISO 14971, MDR (2017/745) and 21 CFR 820.
  • BS/MS degree in Engineering or related science discipline. An advanced degree is a plus.
  • Business fluent (written and oral) in English required, French or German a plus.
Responsibilities
  • Establish and maintain the global device risk management processes.
  • Perform risk management according to ISO 14971 (risk management planning, hazard and harms list, Risk management reports…) and assists medical device sites in ensuring that risk management is performed in sufficient detail and in a timely manner for new device introductions and regulatory agency inspections.
  • Ensure that project teams utilize appropriate risk analysis tools to assure that the Risk Management requirements are met.
  • Develop and deploy appropriate Risk Management training for various internal and external Sanofi functions.
  • Provide appropriate support to remediation of risk management files.
  • Provide expertise and guidance to ensure a harmonized approach for all development and lifecycle management programs and perform Risk Management activities aligned with ISO 14971 including the update to Risk Management File based on post-market surveillance.
  • Partner with other quality, compliance, development, and manufacturing groups to enable transparency, escalation, and action to resolve patient-safety-related issues.
  • Establish and maintain linkages to other relevant risk management groups within Sanofi (e.g. Quality Risk Management, Technical Committee).
  • Interface with network sites for device RMF-related topics.
  • Oversee trend outputs of market complaints within the network to identify possible multi-site impacts and implement the required corrective and/or preventive actions. If new risks are identified (failure modes) requiring an update of the risk analyses (pFMEA, dFMEA, use FMEA), notification of the impact to network sites.
  • Interact with internal and external teams (engineering/product development /regulatory/ suppliers) to define the plan, timelines and strategy for development of the Clinical evaluation reports.
  • Support implementation of Design Controls elements per relevant procedures for new product development or design changes including Design History File (DHF) Maintenance.
  • Support Supplier Quality Engineering activities.
  • Support continuous improvement of projects or activities.
  • Provide quality engineering support for Manufacturing Technology activities (includes but not limited to validation, transfer, supplier selection, and quality control plan).
  • Perform Impact Assessment of change controls (components, products, platforms, and processes).

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology portfolio.
  • Dupixent's EU approval expands Sanofi's pediatric treatment offerings.
  • Sanofi's investment in Zucara Therapeutics strengthens its diabetes treatment pipeline.

What critics are saying

  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Competition in multiple sclerosis market could impact tolebrutinib's market share.
  • AI tools like Muse may face challenges from stringent data privacy regulations.

What makes Sanofi unique

  • Sanofi's partnership with BrightInsight enhances digital health solutions for specialty therapies.
  • Tolebrutinib is the first brain-penetrant BTK inhibitor for multiple sclerosis.
  • Sanofi's Muse AI tool optimizes patient recruitment in clinical trials.

Help us improve and share your feedback! Did you find this helpful?